l O2 slightly better (they had warned end of July), automotive margins strong (trading +5.6%) • Novozymes ebit and revenues both beat expectations, BioEnergy division stronger (trading +1.8%) • Balfour Beatty sells UK facilities business for £190 million, decent short interest in the name (trading -0.36%